As of 2025-07-07, the Fair Value of Dr Hoenle AG (HNL.DE) is -10.69 EUR. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 9.44 EUR, the upside of Dr Hoenle AG is -213.20%.
With the market price of 9.44 EUR and our fair value calculation, Dr Hoenle AG (HNL.DE) is not a good investment. Investing in HNL.DE stocks now will result in a potential loss of 213.20%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 5Y Avg | |
| Net income | 5.68 | -4.82 | -13.36 | -11.01 | -13.28 | -7.36 |
| YoY growth | -54.49% | -184.89% | -177.20% | 17.63% | -20.67% | -83.93% |
| Market Cap (mil) | 57.21 |
| P/E | |
| Forward P/E |
| EPS | -2.14 |
| Avg earnings growth rate | -83.93% |
| TTM earnings | -12.95 |